Electrochemical and theoretical studies of the interaction between anticancer drug ponatinib and dsDNA

Abstract In this study, electrochemical and theoretical studies were performed to explain the interaction mechanism between ponatinib (PNT), a third generation tyrosine kinase inhibitor, and dsDNA. The electrochemical part was conducted in phosphate-buffered saline (PBS) at physiological pH of 7.4 a...

Full description

Bibliographic Details
Main Authors: Sylwia Smarzewska, Anna Ignaczak, Kamila Koszelska
Format: Article
Language:English
Published: Nature Portfolio 2024-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-52609-z
_version_ 1797276531333005312
author Sylwia Smarzewska
Anna Ignaczak
Kamila Koszelska
author_facet Sylwia Smarzewska
Anna Ignaczak
Kamila Koszelska
author_sort Sylwia Smarzewska
collection DOAJ
description Abstract In this study, electrochemical and theoretical studies were performed to explain the interaction mechanism between ponatinib (PNT), a third generation tyrosine kinase inhibitor, and dsDNA. The electrochemical part was conducted in phosphate-buffered saline (PBS) at physiological pH of 7.4 and in acetate buffer with a pH of 4.7, using square wave voltammetry. A boron-doped diamond electrode was used in a bulk-incubated solution. The theoretical part was investigated using computational methods, such as the semiempirical method PM7 and density functional theory (DFT). Significant differences in the electrochemical behavior of PNT in the presence of DNA confirmed the occurrence of interactions. The results obtained in the acetate buffer strongly suggested the preferential interaction of PNT with guanine residues. However, at physiological pH, it can be concluded that PNT interacts with dGua and dAdo in the dsDNA molecule. These results are consistent with outcomes from the theoretical studies, where quantum-chemical calculations showed that both electrochemically detectable nucleobases form hydrogen bonds with the drug. These bonds appeared to be stronger with guanine than with adenine. According to the computational studies, the dsDNA major groove is the energetically preferred site for the complexation of PNT.
first_indexed 2024-03-07T15:29:31Z
format Article
id doaj.art-3c6f061dc9334f8780258573927a61fe
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-07T15:29:31Z
publishDate 2024-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-3c6f061dc9334f8780258573927a61fe2024-03-05T16:28:54ZengNature PortfolioScientific Reports2045-23222024-01-0114111410.1038/s41598-024-52609-zElectrochemical and theoretical studies of the interaction between anticancer drug ponatinib and dsDNASylwia Smarzewska0Anna Ignaczak1Kamila Koszelska2Department of Inorganic and Analytical Chemistry, University of LodzDepartment of Physical Chemistry, University of LodzDepartment of Inorganic and Analytical Chemistry, University of LodzAbstract In this study, electrochemical and theoretical studies were performed to explain the interaction mechanism between ponatinib (PNT), a third generation tyrosine kinase inhibitor, and dsDNA. The electrochemical part was conducted in phosphate-buffered saline (PBS) at physiological pH of 7.4 and in acetate buffer with a pH of 4.7, using square wave voltammetry. A boron-doped diamond electrode was used in a bulk-incubated solution. The theoretical part was investigated using computational methods, such as the semiempirical method PM7 and density functional theory (DFT). Significant differences in the electrochemical behavior of PNT in the presence of DNA confirmed the occurrence of interactions. The results obtained in the acetate buffer strongly suggested the preferential interaction of PNT with guanine residues. However, at physiological pH, it can be concluded that PNT interacts with dGua and dAdo in the dsDNA molecule. These results are consistent with outcomes from the theoretical studies, where quantum-chemical calculations showed that both electrochemically detectable nucleobases form hydrogen bonds with the drug. These bonds appeared to be stronger with guanine than with adenine. According to the computational studies, the dsDNA major groove is the energetically preferred site for the complexation of PNT.https://doi.org/10.1038/s41598-024-52609-z
spellingShingle Sylwia Smarzewska
Anna Ignaczak
Kamila Koszelska
Electrochemical and theoretical studies of the interaction between anticancer drug ponatinib and dsDNA
Scientific Reports
title Electrochemical and theoretical studies of the interaction between anticancer drug ponatinib and dsDNA
title_full Electrochemical and theoretical studies of the interaction between anticancer drug ponatinib and dsDNA
title_fullStr Electrochemical and theoretical studies of the interaction between anticancer drug ponatinib and dsDNA
title_full_unstemmed Electrochemical and theoretical studies of the interaction between anticancer drug ponatinib and dsDNA
title_short Electrochemical and theoretical studies of the interaction between anticancer drug ponatinib and dsDNA
title_sort electrochemical and theoretical studies of the interaction between anticancer drug ponatinib and dsdna
url https://doi.org/10.1038/s41598-024-52609-z
work_keys_str_mv AT sylwiasmarzewska electrochemicalandtheoreticalstudiesoftheinteractionbetweenanticancerdrugponatinibanddsdna
AT annaignaczak electrochemicalandtheoreticalstudiesoftheinteractionbetweenanticancerdrugponatinibanddsdna
AT kamilakoszelska electrochemicalandtheoreticalstudiesoftheinteractionbetweenanticancerdrugponatinibanddsdna